ADx NeuroSciences
Technologiepark 94
9000 Zwijnaarde
BE
ADx NeuroSciences
Foundation date
16/09/2011
Sector
#Biotechnology - TherapeuticsSubsector
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.
Upcoming events
All events-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
1610 '24
FIGON Dutch Medicines Days
Event by: Hyphen Projects
Latest news
More news-
Scientists discover viral trapdoor blocking HIV and herpes
1 day ago
Read more
-
UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility
Tuesday October 8th 2024
Read more
-
Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth
Monday October 7th 2024
Read more
Jobs by ADx NeuroSciences
More jobsMore info?
Ellen Telleir
Communication Coordinator